Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 3/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ERN1 | O75460 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29692497 | 0.82 | ALOX5 (0.57) | MAOBALOX5PTGS2ESR1ESR2 | |
| SCHEMBL517614 | 0.82 | ALOX5 (0.57) | MAOBALOX5PTGS2ESR1ESR2 | |
| SCHEMBL9623648 | 0.81 | MAOB (0.67) | MAOBALOX5PTGS2ESR1ESR2 | |
| SCHEMBL119396 | 0.78 | MAOB (0.70) | MAOBPTGS2ESR1ESR2MAPT | |
| SCHEMBL30514387 | 0.78 | MAOB (0.70) | MAOBPTGS2ESR1ESR2MAPT | |
| SCHEMBL9122395 | 0.78 | BACE1 (0.46) | MAOBALOX5PTGS2ESR1ESR2 | |
| SCHEMBL9939154 | 0.78 | ESR1 (0.57) | MAOBALOX5PTGS2ESR1ESR2 | |
| SCHEMBL4677324 | 0.77 | MAOB (0.41) | MAOBALOX5PTGS2ESR1ESR2 | |
| SCHEMBL1697735 | 0.77 | TSHR (0.44) | MAOBMAPTGAAALDH1A1MEN1 | |
| SCHEMBL15384783 | 0.77 | SLC6A4 (0.49) | MAOBALOX5PTGS2MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 690 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058566-A | Synthesis method and application of trifluoro-methanesulfonyl ester substituted macrocyclic aromatic hydrocarbon | 天津师范大学 | 2025-05-30 | — | — | CN | claimed |
| CN-119119040-A | Preparation method of non-neridrone intermediate | 广西天铭药业有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118930433-A | Preparation method and application of serial functional conjugated nano-rings containing ring para-phenylene skeleton | 天津师范大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118638106-A | Novel method for synthesizing hexamethylation sophoraflavanone J | 西南交通大学 | 2024-09-13 | — | — | CN | claimed |
| CN-110317129-A | The synthetic method of the bromo- 5- metoxyphenol of 2- | 杭州迈世腾药物科技有限公司 | 2019-10-11 | — | — | CN | claimed |
| CN-105348799-A | Nitrogen compound flame retardant and preparation method thereof | NINGXIA RUNLONG PACKAGING MATERIAL CO LTD | 2016-02-24 | — | — | CN | claimed |
| CN-101910308-B | Curing composition and cured product prepared by using the same | LG CHEMICAL LTD | 2012-11-21 | — | — | CN | claimed |
| CN-101910308-A | Curing composition and cured product prepared by using the same | LG CHEMICAL LTD | 2010-12-08 | — | — | CN | claimed |
| EP-0351336-B1 | PROCESS FOR THE PREPARATION OF HYDROXYBENZALDEHYDES BY HYDROCARBONYLATION | RHONE-POULENC CHIMIE (FR) | 1992-10-28 | — | — | EP | claimed |
| US-12595243-B2 | Modulators of extracellular signal-regulated kinase | GEN1E LIFESCIENCES INC. (US) | 2026-04-07 | — | — | US | disclosed |
| EP-3526196-B1 | ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS | MERCK SHARP & DOHME LLC (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12570607-B2 | Compound as cyclin-dependent kinase 9 inhibitor and use thereof | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) | 2026-03-10 | — | — | US | disclosed |
| US-12509460-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-12492344-B2 | Liquid-crystal medium comprising polymerizable compounds | MERCK PATENT GMBH (DE) | 2025-12-09 | — | — | US | disclosed |
| US-3980659-A | INSECTICIDES, INTERMEDIATES FOR AZO DYES | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-09-14 | — | — | US | disclosed |
| US-3959388-A | Preparation of phloroglucinol or its monomethyl ether | ANDENO B.V. (NL) | 1976-05-25 | — | — | US | disclosed |
| US-3956294-A | AZO DYES, PESTICIDES, ANALEPTICS, ANALGESICS, DIURETICS | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-05-11 | — | — | US | disclosed |
| US-3954782-A | 2,6-Hydrazino-3-pyridine carboxyamides | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
| US-3947463-A | Certain 2-amino-nicotinonitrile derivatives | CASSELLA FARBWERKE MAINKUR AG (DT) | 1976-03-30 | — | — | US | disclosed |
| US-3946024-A | INTERMEDIATES FOR AZO DYES | CASSELLA FARBWERKE MAINKUR AG (DT) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509460-B2 | Methods and compositions for modulating splicing | SF3B1, RTCB, RBM17 | MAOB 3315/4885ALOX5 1855/4885PTGS2 2820/4885 |
| US-12570607-B2 | Compound as cyclin-dependent kinase 9 inhibitor and use thereof | CDK9, CDK4, CDKL4 | MAOB 4091/4885ALOX5 4775/4885PTGS2 3250/4885 |
| US-12492344-B2 | Liquid-crystal medium comprising polymerizable compounds | NEFM, LPXN, SPAST | MAOB 1827/4885ALOX5 1342/4885PTGS2 4473/4885 |
| US-12595243-B2 | Modulators of extracellular signal-regulated kinase | CDC42BPG, GRK3, ERBB2 | MAOB 3970/4885ALOX5 3342/4885PTGS2 1220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.